SUDEEP PHARMA
Back to Cashflow Statement
|
SUDEEP PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹53 Cr | ₹-13 Cr | ₹-9.78 Cr | ₹51 Cr | ₹13 Cr |
What is the latest Cash Flow from Financing Activities ratio of SUDEEP PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹53 Cr |
| Mar2024 | ₹-13 Cr |
| Mar2023 | ₹-9.78 Cr |
| Mar2022 | ₹51 Cr |
| Mar2021 | ₹13 Cr |
How is Cash Flow from Financing Activities of SUDEEP PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹53 Cr | Positive | |
| Mar2024 | ₹-13 Cr | Negative | |
| Mar2023 | ₹-9.78 Cr | Negative | |
| Mar2022 | ₹51 Cr | 291.72 | |
| Mar2021 | ₹13 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SUDEEP PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDEEP PHARMA | ₹9,568.3 Cr | 0.8% | 14.3% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,924.0 Cr | -0.3% | 3.4% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,619.0 Cr | -2.5% | -1.2% | -1.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹156,450.0 Cr | 2.4% | 5.2% | 47.2% | Stock Analytics | |
| CIPLA | ₹118,361.0 Cr | 2.2% | 4.8% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,253.0 Cr | 4.3% | 4.1% | 4.5% | Stock Analytics | |
SUDEEP PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDEEP PHARMA | 0.8% |
14.3% |
|
| SENSEX | -0.8% |
0.8% |
-7.2% |
You may also like the below Video Courses